Search research articles
Contact Us
Filters
Showing results (141-150 of 155) with videos related to
Page
of 16
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1997
Dose-intensity of a four-drug chemotherapy regimen with or without recombinant human granulocyte-macrophage colony-stimulating factor in extensive-stage small-cell lung cancer: a multicenter randomized phase III study
J L Pujol, J Y Douillard, A Rivière, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 9, 2010
Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01)
C Le Péchoux, A Laplanche, C Faivre-Finn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 18, 2003
Randomised, multicentre phase II study assessing two doses of docetaxel (75 or 100 mg/m2) as second-line monotherapy for non-small-cell lung cancer
E Quoix, B Lebeau, A Depierre, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 16, 2001
Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Français de Pneumo-Cancérologie (GFPC) Protocol 95-1
G Robinet, P Thomas, J L Breton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 24, 1997
Long-term survivors of small-cell lung cancer (SCLC): a French multicenter study. Groupe d'Oncologie de Langue Française
P Jacoulet, A Depierre, D Moro, et al.
ESMO Open
|
December 25, 2021
IFCT-1502 CLINIVO: real-world evidence of long-term survival with nivolumab in a nationwide cohort of patients with advanced non-small-cell lung cancer
O Molinier, B Besse, F Barlesi, et al.
Revue Des Maladies Respiratoires
|
May 24, 2007
[IFCT-0302 trial: randomised study comparing two follow-up schedules in completely resected non-small cell lung cancer]
V Westeel, M P Lebitasy, M Mercier, et al.
Revue Des Maladies Respiratoires
|
July 17, 2007
[Lung cancer in the elderly subject]
, G Albrand, E Biron, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 18, 2015
Randomized phase II-III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: results from the IFCT-0802 trial†
J-L Pujol, A Lavole, E Quoix, et al.
Revue Des Maladies Respiratoires
|
January 28, 2014
[Individual lung cancer screening in practice. Perspectives on the propositions from the multidisciplinary group of the Intergroupe francophone de cancérologie thoracique, the Société d'imagerie thoracique and the Groupe d'oncologie de langue française]
N Girard, V Gounant, B Mennecier, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 155) with videos related to
Sort By:
Page
of 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1997
Dose-intensity of a four-drug chemotherapy regimen with or without recombinant human granulocyte-macrophage colony-stimulating factor in extensive-stage small-cell lung cancer: a multicenter randomized phase III study
J L Pujol, J Y Douillard, A Rivière, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 9, 2010
Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01)
C Le Péchoux, A Laplanche, C Faivre-Finn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 18, 2003
Randomised, multicentre phase II study assessing two doses of docetaxel (75 or 100 mg/m2) as second-line monotherapy for non-small-cell lung cancer
E Quoix, B Lebeau, A Depierre, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 16, 2001
Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Français de Pneumo-Cancérologie (GFPC) Protocol 95-1
G Robinet, P Thomas, J L Breton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 24, 1997
Long-term survivors of small-cell lung cancer (SCLC): a French multicenter study. Groupe d'Oncologie de Langue Française
P Jacoulet, A Depierre, D Moro, et al.
ESMO Open
|
December 25, 2021
IFCT-1502 CLINIVO: real-world evidence of long-term survival with nivolumab in a nationwide cohort of patients with advanced non-small-cell lung cancer
O Molinier, B Besse, F Barlesi, et al.
Revue Des Maladies Respiratoires
|
May 24, 2007
[IFCT-0302 trial: randomised study comparing two follow-up schedules in completely resected non-small cell lung cancer]
V Westeel, M P Lebitasy, M Mercier, et al.
Revue Des Maladies Respiratoires
|
July 17, 2007
[Lung cancer in the elderly subject]
, G Albrand, E Biron, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 18, 2015
Randomized phase II-III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: results from the IFCT-0802 trial†
J-L Pujol, A Lavole, E Quoix, et al.
Revue Des Maladies Respiratoires
|
January 28, 2014
[Individual lung cancer screening in practice. Perspectives on the propositions from the multidisciplinary group of the Intergroupe francophone de cancérologie thoracique, the Société d'imagerie thoracique and the Groupe d'oncologie de langue française]
N Girard, V Gounant, B Mennecier, et al.
Page
of 16